MedPath

Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation

Not Applicable
Active, not recruiting
Conditions
Healthy
Interventions
Device: Philips FAST SpO2 with Masimo Pulse Oximetry Sensors
Registration Number
NCT06148623
Lead Sponsor
Masimo Corporation
Brief Summary

Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test SubjectPhilips FAST SpO2 with Masimo Pulse Oximetry SensorsAll subjects who are enrolled into the test group and participate in data collection have the Philips FAST SpO2 with Masimo Pulse Oximetry Sensors
Primary Outcome Measures
NameTimeMethod
Oxygen saturation performance of Philips FAST SpO2 with Masimo pulse oximetry sensors1-3 hours

Performance will be determined by calculating the average root mean square (ARMS) comparing the noninvasive oxygen saturation measurement (SpO2) to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample.

Secondary Outcome Measures
NameTimeMethod
Difference in oxygen saturation performance between three population subgroups1-3 hours

Average root mean square (ARMS) will be computed for each pigmentation subgroup for light, medium, and dark skin pigmentation and the difference between the subgroup ARMS will be calculated.

Trial Locations

Locations (1)

Masimo Corporation

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath